Sigma Healthcare Says Normalized EBIT Growth Consistent With Chemist Warehouse's Fiscal H1 Results

MT Newswires Live

May 06, 2025

Sigma Healthcare (ASX:SIG) said that growth in its normalized earnings before taxes and interest (EBIT) for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.

Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.

The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.

Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2533659601"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533659601\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533659601?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-06 08:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533659601","market":"sg","top_or_hot":-1,"title":"Sigma Healthcare Says Normalized EBIT Growth Consistent With Chemist Warehouse's Fiscal H1 Results","media":"MT Newswires Live","content":"<html><body><p> Sigma Healthcare (ASX:<a href=\"https://laohu8.com/S/SHI.UK\">SIG</a>) said that growth in its normalized earnings before taxes and interest (EBIT) for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.</p><p>Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.</p><p>The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.</p><p>Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sigma Healthcare Says Normalized EBIT Growth Consistent With Chemist Warehouse's Fiscal H1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSigma Healthcare Says Normalized EBIT Growth Consistent With Chemist Warehouse's Fiscal H1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-06 08:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Sigma Healthcare (ASX:<a href=\"https://laohu8.com/S/SHI.UK\">SIG</a>) said that growth in its normalized earnings before taxes and interest (EBIT) for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.</p><p>Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.</p><p>The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.</p><p>Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EBIT","symbol_name":"Harbor AlphaEdge Small Cap Earners ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533659601","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533659601","pubTimestamp":1746492977,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Sigma Healthcare  said that growth in its normalized earnings before taxes and interest  for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EBIT":"Harbor AlphaEdge Small Cap Earners ETF","BK4137":"综合支持服务","HCSG":"Healthcare Svcs Group Inc","SIG.AU":"SIGMA HEALTHCARE LTD","BK7103":"保健护理产品经销商"},"translate_title":"Sigma Healthcare表示息税前利润正常化增长与Chemist Warehouse上半年财报一致","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIG.AU":0.9,"EBIT":1,"HCSG":1},"content_text":"Sigma Healthcare (ASX:SIG) said that growth in its normalized earnings before taxes and interest (EBIT) for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}